Last reviewed 2026-04-23 · How we verify

GW642444H

GlaxoSmithKline · Phase 2 active Small molecule

At a glance

Generic name	GW642444H
Sponsor	GlaxoSmithKline
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study To Assess The Safety And Tolerability Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (PHASE2)
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients (PHASE1)
A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients. (PHASE2)
Study to Assess GW642444 in Asthma Patients (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results